Medical device company developing technologies for the early detection and treatment of breast cancer. Acquired by Cytyc Corporation (NASDAQ: CYTC) for $167.5 million.       Developer of innovative tools for minimally invasive surgery. The focus is on breast biopsies, surgeries and lesion ablation. Sold to Tyco International for $100M July 5, 2005.